Growth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor I
- PMID: 18182451
- PMCID: PMC2291494
- DOI: 10.1210/jc.2007-2021
Growth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor I
Abstract
Context: Endothelial dysfunction is common in patients with GH deficiency who are at increased risk for premature cardiovascular death. GH regulates vascular tone and reactivity in humans.
Objective: Our objective was to explore the mechanisms underlying the GH's acute vascular effects. DESIGN AND STUDY SETTING: There were 10 healthy, lean and young, volunteers studied after an overnight fast. GH was infused systemically for 6 h at 0.06 microg/kg.min. Biopsy of the vastus lateralis muscle was done in seven subjects before and after GH infusion. Human aortic endothelial cells (HAECs) were incubated with GH in vitro.
Results: GH infusion increased plasma GH to 32.9 +/- 1.5 ng/ml and forearm blood flow by 66% (P < 0.001). GH infusion did not significantly change plasma IGF-I concentrations, muscle IGF-I mRNA expression, and muscle Akt phosphorylation, suggesting a lack of IGF-I action in muscle. Because it was reported that GH exerts an acute vascular effect via a nitric oxide (NO)-dependent mechanism, we performed additional in vitro experiments using HAECs. HAECs express abundant GH receptors. Incubating HAECs with GH at 30 ng/ml for 3 or 6 h did not alter endothelial NO synthase (eNOS) protein content but time dependently increased the phosphorylation and activity of eNOS, thus demonstrating a direct effect of GH on endothelial cells.
Conclusions: GH exerts an acute vascular effect independent of both systemic and local IGF-I production, and this effect is likely via direct action on GH receptors and eNOS in the vascular endothelium.
Figures





Similar articles
-
Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.Circ Res. 2007 Feb 16;100(3):434-43. doi: 10.1161/01.RES.0000257912.78915.af. Epub 2007 Jan 18. Circ Res. 2007. PMID: 17234973
-
Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade.J Clin Endocrinol Metab. 2008 Jul;93(7):2842-50. doi: 10.1210/jc.2007-2414. Epub 2008 May 6. J Clin Endocrinol Metab. 2008. PMID: 18460563 Clinical Trial.
-
NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF- I: possible role of nitric oxide in muscle protein synthesis.J Clin Invest. 1996 Mar 1;97(5):1319-28. doi: 10.1172/JCI118548. J Clin Invest. 1996. PMID: 8636445 Free PMC article.
-
Growth hormone and the heart.Miner Electrolyte Metab. 1999 Jan-Apr;25(1-2):51-5. doi: 10.1159/000057420. Miner Electrolyte Metab. 1999. PMID: 10207260 Review.
-
Potential Roles of Vascular Endothelial Growth Factor During Skeletal Muscle Hypertrophy.Exerc Sport Sci Rev. 2018 Jul;46(3):195-202. doi: 10.1249/JES.0000000000000152. Exerc Sport Sci Rev. 2018. PMID: 29652692 Review.
Cited by
-
The prolactin family hormones regulate vascular tone through NO and prostacyclin production in isolated rat aortic rings.Acta Pharmacol Sin. 2015 May;36(5):572-86. doi: 10.1038/aps.2014.159. Epub 2015 Apr 20. Acta Pharmacol Sin. 2015. PMID: 25891087 Free PMC article.
-
Effects of Puberty on Blood Pressure Trajectories - Underlying Processes.Curr Hypertens Rep. 2023 Jul;25(7):117-125. doi: 10.1007/s11906-023-01241-9. Epub 2023 Apr 18. Curr Hypertens Rep. 2023. PMID: 37071287 Free PMC article. Review.
-
Cell non-autonomous regulation of cerebrovascular aging processes by the somatotropic axis.Front Endocrinol (Lausanne). 2023 Jan 23;14:1087053. doi: 10.3389/fendo.2023.1087053. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36755922 Free PMC article. Review.
-
Sitagliptin Decreases Visceral Fat and Blood Glucose in Women With Polycystic Ovarian Syndrome.J Clin Endocrinol Metab. 2020 Jan 1;105(1):136-51. doi: 10.1210/clinem/dgz028. J Clin Endocrinol Metab. 2020. PMID: 31529097 Free PMC article. Clinical Trial.
-
Chronic limb-threatening ischemia could benefit from growth hormone therapy for wound healing and limb salvage.Ther Adv Cardiovasc Dis. 2018 Feb;12(2):53-72. doi: 10.1177/1753944717745494. Epub 2017 Dec 22. Ther Adv Cardiovasc Dis. 2018. PMID: 29271292 Free PMC article. Review.
References
-
- Gola M, Bonadonna S, Doga M, Giustina A 2005 Growth hormone and cardiovascular risk factors. J Clin Endocrinol Metab 90:1864–1870 - PubMed
-
- Lerman A, Zeiher AM 2005 Endothelial function: cardiac events. Circulation 111:363–368 - PubMed
-
- Capaldo B, Guardasole V, Pardo F, Matarazzo M, Di Rella F, Numis F, Merola B, Longobardi S, Sacca L 2001 Abnormal vascular reactivity in growth hormone deficiency. Circulation 103:520–524 - PubMed
-
- Napoli R, Guardasole V, Angelini V, D’Amico F, Zarra E, Matarazzo M, Sacca L 2003 Acute effects of growth hormone on vascular function in human subjects. J Clin Endocrinol Metab 88:2817–2820 - PubMed
-
- Fryburg DA, Barrett EJ 1993 Growth hormone acutely stimulates skeletal muscle but not whole-body protein synthesis in humans. Metabolism 42:1223–1227 - PubMed